Mostrar el registro sencillo del ítem
Correlation of focal adhesion kinase expression with nodal metastasis in patients with head and neck cutaneous squamous cell carcinoma
dc.contributor.author | Munguía-Calzada P. | |
dc.contributor.author | Fernández-Vega I. | |
dc.contributor.author | Martínez-Camblor P. | |
dc.contributor.author | Díaz-Coto S. | |
dc.contributor.author | García-Pedrero J.M. | |
dc.contributor.author | Vivanco B. | |
dc.contributor.author | Osuna C.G. | |
dc.contributor.author | Vazquez-Lopez F. | |
dc.contributor.author | Rodrigo J.P. | |
dc.contributor.author | Santos-Juanes J. | |
dc.date.accessioned | 2020-09-02T22:23:45Z | |
dc.date.available | 2020-09-02T22:23:45Z | |
dc.date.issued | 2019 | |
dc.identifier | 10.1002/hed.25556 | |
dc.identifier.citation | 41, 5, 1290-1296 | |
dc.identifier.issn | 10433074 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/5468 | |
dc.description | Background: Focal adhesion kinase (FAK) and cortactin overexpression is frequently detected in a variety of cancers, and has been associated with poor clinical outcome. However, there are no data in cutaneous squamous cell carcinoma (cSCC). Objective: To investigate the relationship of FAK and cortactin expression with the clinicopathologic features and the impact on the prognosis of cSCC patients. Methods: FAK and cortactin expression was analyzed by immunohistochemistry on paraffin-embedded tissue samples from 100 patients with cSCC, and correlated with the clinical data. Results: FAK overexpression was a significant risk factor for nodal metastasis with crude and adjusted ratios (HRs) of 2.04, (95% CI [1.08-3.86], [P = 0.029]) and 2.23 (95% CI [1.01-4.91], [P = 0.047]), respectively. Cortactin expression was not a significant risk factor for nodal metastasis. Conclusion: These findings demonstrate that FAK overexpression is an independent predictor of nodal metastasis that might be helpful for risk stratification and management of patients with cSCC. © 2018 Wiley Periodicals, Inc. | |
dc.language.iso | en | |
dc.publisher | John Wiley and Sons Inc. | |
dc.subject | cortactin | |
dc.subject | cutaneous squamous cell carcinoma | |
dc.subject | focal adhesion kinase | |
dc.subject | nodal metastasis | |
dc.subject | prognosis | |
dc.subject | cortactin | |
dc.subject | focal adhesion kinase | |
dc.subject | aged | |
dc.subject | Article | |
dc.subject | cancer prognosis | |
dc.subject | cancer size | |
dc.subject | cancer staging | |
dc.subject | cancer surgery | |
dc.subject | controlled study | |
dc.subject | female | |
dc.subject | head and neck squamous cell carcinoma | |
dc.subject | human | |
dc.subject | human tissue | |
dc.subject | immunohistochemistry | |
dc.subject | lymph node metastasis | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | metastasis free survival | |
dc.subject | overall survival | |
dc.subject | perineural invasion | |
dc.subject | primary tumor | |
dc.subject | priority journal | |
dc.subject | protein expression | |
dc.subject | skin carcinoma | |
dc.subject | survival rate | |
dc.subject | tissue microarray | |
dc.title | Correlation of focal adhesion kinase expression with nodal metastasis in patients with head and neck cutaneous squamous cell carcinoma | |
dc.type | Article |